Workflow
Personalized biochemistry technology
icon
Search documents
Profusa, Inc. Provides Strategy Overview and Business Update for Investors
Globenewswire· 2025-08-06 12:15
BERKELEY, Calif, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, provides a strategy overview and business update from Chairman and CEO, Ben Hwang, Ph.D. in the following Letter to Shareholders: To our valued shareholders, In the last two months, Profusa has achieved significant milestones, including s ...